First Header Logo Second Header Logo

Connection

Roy Hantgan to Time Factors

This is a "connection" page, showing publications Roy Hantgan has written about Time Factors.
Connection Strength

0.104
  1. Hantgan RR, Jerome WG, Hursting MJ. No effect of clot age or thrombolysis on argatroban's inhibition of thrombin. Blood. 1998 Sep 15; 92(6):2064-74.
    View in: PubMed
    Score: 0.024
  2. Handt S, Jerome WG, Tietze L, Hantgan RR. Plasminogen activator inhibitor-1 secretion of endothelial cells increases fibrinolytic resistance of an in vitro fibrin clot: evidence for a key role of endothelial cells in thrombolytic resistance. Blood. 1996 May 15; 87(10):4204-13.
    View in: PubMed
    Score: 0.021
  3. Braaten JV, Jerome WG, Hantgan RR. Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface. Blood. 1994 Feb 15; 83(4):982-93.
    View in: PubMed
    Score: 0.018
  4. Hantgan RR, Braaten JV, Rocco M. Dynamic light scattering studies of alpha IIb beta 3 solution conformation. Biochemistry. 1993 Apr 20; 32(15):3935-41.
    View in: PubMed
    Score: 0.017
  5. Carlisle CR, Coulais C, Namboothiry M, Carroll DL, Hantgan RR, Guthold M. The mechanical properties of individual, electrospun fibrinogen fibers. Biomaterials. 2009 Feb; 30(6):1205-13.
    View in: PubMed
    Score: 0.012
  6. Mizel SB, Graff AH, Sriranganathan N, Ervin S, Lees CJ, Lively MO, Hantgan RR, Thomas MJ, Wood J, Bell B. Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates. Clin Vaccine Immunol. 2009 Jan; 16(1):21-8.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.